✳flâneur — a map of the web's best reading
新冠疫苗再添生力軍!賽諾菲/GSK 疫苗二期呈「強烈免疫反應」 | TechNews 科技新報
technews.tw · 673 words · saved by 1 readers
法國藥廠賽諾菲(Sanofi)與英國葛蘭素史克藥廠(GSK)今日發表報告指出,雙方共同研發的新冠肺炎(COVID-19)疫苗在第二期臨床試驗呈現「強烈免疫反應」,預計將在未來幾週啟動第三期臨床試驗,代表又有一支新冠疫苗可望加入抗疫行列,目標今年第 4 季可以獲批上市。 賽諾菲和葛蘭素史...
in window ) msGesture window.DocumentTouch && document instanceof DocumentTouch) && slider.vars.touch, // depricating this idea, as devices are being released with both of these events eventType = ) slider.controlsContainer = $(slider.vars.controlsContainer).length > 0 && $(slider.vars.controlsContainer); // MANUAL: if (slider.vars.manualControls !== ) slider.manualControls = $(slider.vars.manualControls).length > 0 && $(slider.vars.manualControls); // CUSTOM DIRECTION NAV: if (slider.vars.customDirectionNav !== ) { slideString = (reverse) ? 0 : (slider.count + 1) * dimension; } else { slideSt
Explore this link on the map →related reading
- GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine | GSK | The Guardiantheguardian.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- COVID-19病毒變身全解析:從Alpha、Delta到Omicron,重要變異怎麼發生?疫苗保護力追得上嗎? - 報導者 The Reportertwreporter.org
- Frontiers | Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective studyfrontiersin.org
- 英美商合作藥物獲美緊急授權 治輕中度染疫患者 | 國際 | 中央社 CNAcna.com.tw
- The Frontier in 2025renaissancephilanthropy.org
- No, vaccine side effects don’t tell you how well your immune system will protect you from COVID-19theconversation.com
- 【獨家披露合約內容】國產疫苗二期期中報告出爐後兩大難題:專家委員利益衝突爭議、交貨期程排到年底 - 報導者 The Reportertwreporter.org
- What We Learned Doing Fast Grants | Futurefuture.a16z.com
- GSK and Vir Biotechnology enter collaboration to find coronavirus solutions | GSKgsk.com
- Omicron: ce que vous devez savoir sur le nouveau variant du Covid-19 | Slate.frslate.fr
- Shibboleth Authentication Requestpmc-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca